Alvotech (ALVO) Non Operating Income (2022 - 2024)
Alvotech's (ALVO) quarterly Non Operating Income came in at -$287.2 million in Q4 2024, up 3.03% YoY from -$278.8 million in Q1 2024, and down 162395.19% on a QoQ basis from -$176748.0 in Q1 2024.
Alvotech (ALVO) Non Operating Income (2022 - 2024) Analysis & Trends
Alvotech (ALVO) has 3 years of Non Operating Income data on file, last reported at -$287.2 million in Q4 2024.
- Quarterly Non Operating Income rose 3.03% year-over-year to -$287.2 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$583.8 million (down 11.31% YoY) and the FY2023 annual result came in at -$296.2 million, changed N/A from the prior year.
- Non Operating Income declined to -$287.2 million in Q4 2024, from -$176748.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of -$176748.0 in Q1 2024 to a low of -$296.2 million in Q4 2023.
- A 3-year average of -$135.3 million and a median of -$114.0 million in 2022 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 99.08% in 2023, down 44.34% in 2023.
- Tracing ALVO's Non Operating Income over 3 years: stood at -$205.2 million in 2022, then plunged by 44.34% to -$296.2 million in 2023, then rose by 3.03% to -$287.2 million in 2024.
- The last three Non Operating Income figures came in at -$287.2 million (Q4 2024), -$176748.0 (Q1 2024), and -$296.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alvotech | 1.30 Bn | 1.30 Bn | 5.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -287.21 Mn |
| Mar 31, 2024 | -176,748.00 |
| Dec 31, 2023 | -296.19 Mn |
| Mar 31, 2023 | -209,286.00 |
| Dec 31, 2022 | -205.21 Mn |
| Mar 31, 2022 | -22.87 Mn |